Constitutive activation of the phosphatidylinositol-3-OH kinase (PI3K) and RAS signaling pathways are important events in tumor formation. This is illustrated by the frequent genetic alteration of several key players from these pathways in a wide variety of human cancers. Here, we report a detailed sequence analysis of th
<p>The Ras family of proteins, composed of H, N, and KRas, function as small GTPases that act as "mo...
Ras proteins are essential mediators of a multitude of cellular processes, and its deregulation is f...
Lesions of ERBB2, PTEN, and PIK3CA activate the phosphati- dylinositol 3-kinase (PI3K) pathway durin...
have been identified in various malignancies, and activate the PI3K/AKT/mTOR and RAS/RAF/MEK pathwa...
Lesions of ERBB2, PTEN, and PIK3CA activate the phosphatidylinositol 3-kinase (PI3K) pathway during ...
Oncogenic mutations of PIK3CA, RAS (KRAS, NRAS), and BRAF have been identified in various malignanci...
SummaryWhile tumors become addicted to oncogenes like Ras, the microenvironment in which tumor cells...
The novel phosphatidylinositol-3-kinase (PI3K) inhibitor PX-866 was tested against 13 experimental h...
Ras genes are found mutated in about 30% of all human malignancies, being one of the most frequent m...
The novel phosphatidylinositol-3-kinase (PI3K) inhibitor PX-866 was tested against 13 experimental h...
Abnormally activated RAS proteins are the main oncogenic driver that governs the functioning of majo...
SummaryDysregulation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway occurs frequently...
BackgroundThe phosphatidylinositol 3-kinase (PI3K) pathway is frequently altered in cancer. This rep...
Breast cancer is a common malignancy with current biological therapies tailored to steroid hormone (...
The RAS/MAP kinase and the RAS/PI3K/AKT pathways play a key role in the regulation of proliferation,...
<p>The Ras family of proteins, composed of H, N, and KRas, function as small GTPases that act as "mo...
Ras proteins are essential mediators of a multitude of cellular processes, and its deregulation is f...
Lesions of ERBB2, PTEN, and PIK3CA activate the phosphati- dylinositol 3-kinase (PI3K) pathway durin...
have been identified in various malignancies, and activate the PI3K/AKT/mTOR and RAS/RAF/MEK pathwa...
Lesions of ERBB2, PTEN, and PIK3CA activate the phosphatidylinositol 3-kinase (PI3K) pathway during ...
Oncogenic mutations of PIK3CA, RAS (KRAS, NRAS), and BRAF have been identified in various malignanci...
SummaryWhile tumors become addicted to oncogenes like Ras, the microenvironment in which tumor cells...
The novel phosphatidylinositol-3-kinase (PI3K) inhibitor PX-866 was tested against 13 experimental h...
Ras genes are found mutated in about 30% of all human malignancies, being one of the most frequent m...
The novel phosphatidylinositol-3-kinase (PI3K) inhibitor PX-866 was tested against 13 experimental h...
Abnormally activated RAS proteins are the main oncogenic driver that governs the functioning of majo...
SummaryDysregulation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway occurs frequently...
BackgroundThe phosphatidylinositol 3-kinase (PI3K) pathway is frequently altered in cancer. This rep...
Breast cancer is a common malignancy with current biological therapies tailored to steroid hormone (...
The RAS/MAP kinase and the RAS/PI3K/AKT pathways play a key role in the regulation of proliferation,...
<p>The Ras family of proteins, composed of H, N, and KRas, function as small GTPases that act as "mo...
Ras proteins are essential mediators of a multitude of cellular processes, and its deregulation is f...
Lesions of ERBB2, PTEN, and PIK3CA activate the phosphati- dylinositol 3-kinase (PI3K) pathway durin...